Prognosis

Bernie Sanders’ Surprise for Novo’s CEO in the Ozempic Cost Hearing

Novo Nordisk Chief Executive Officer Lars Fruergaard Jorgensen at the Senate committee hearing in Washington on Tuesday,  Sept. 24. — Novo Nordisk Chief Executive Officer Lars Fruergaard Jorgensen at the Senate committee hearing in Washington on Tuesday, Sept. 24.
Photographer: Al Drago/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Riley Griffin

September 25, 2024 at 10:00 AM UTC

Hi, it’s Riley in Washington. Yesterday, I trekked to Capitol Hill to watch Novo Nordisk’s CEO testify before lawmakers who are angry about the high prices of Ozempic and Wegovy. More on that in a moment, but first ...

I had never seen a more crowded hearing in my time covering Capitol Hill.